Kim Huynh-Ba has been the Executive Director of Pharmalytik. She has 25 years of experience in analytical development, project management, strategic drug development and stability sciences. Prior to Pharmalytik, she was the Director of Pharmacopeial Education Department of U.S. Pharmacopeia (USP), and has held several technical positions at Astra Zeneca (formerly ICI Americas), DuPont Merck, DuPont Pharmaceuticals, Bristol Myers Squibb and Wyeth Vaccines.
Kim is a member of the Executive Committee of Governing Board of Eastern Analytical Symposium (EAS) and was their 2013 President; Chair of USP Good Documentation Practices Expert Panel and member of USP Impurities of Drug Products Expert Panel. She is the editor of Handbook of Stability Testing in Pharmaceutical Development: Regulations, Methodologies and Best Practices (2008) and Pharmaceutical Stability Testing to Support Global Markets (2010) published by Springer.